What is the best antibiotic for traveler's (traveller's) diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotic for Traveler's Diarrhea

Azithromycin is the preferred antibiotic for treating severe traveler's diarrhea, while antibiotic treatment is not recommended for mild cases and may be considered for moderate cases based on clinical presentation. 1

Treatment Approach Based on Severity

Mild Traveler's Diarrhea

  • Antibiotic treatment is not recommended for mild traveler's diarrhea 1
  • Loperamide or bismuth subsalicylate (BSS) may be used for symptomatic relief 1

Moderate Traveler's Diarrhea

  • Antibiotics may be used but are not always necessary 1
  • Azithromycin is recommended with strong evidence (500 mg daily for 3 days or single 1-gram dose) 1
  • Fluoroquinolones may be used but have increasing resistance concerns and potential adverse effects 1
  • Rifaximin (200 mg three times daily for 3 days) may be used for non-invasive, watery diarrhea but should be avoided when invasive pathogens are suspected 1, 2
  • Loperamide can be used as adjunctive therapy or as monotherapy 1

Severe Traveler's Diarrhea

  • Antibiotics should always be used for severe cases 1
  • Azithromycin is the preferred first-line agent for severe traveler's diarrhea, particularly for dysentery 1, 3
  • Single-dose antibiotic regimens are effective and recommended 1, 4
  • Fluoroquinolones may be used for severe non-dysenteric cases but are less preferred due to resistance 1

Evidence for Azithromycin Superiority

  • Azithromycin has demonstrated superior efficacy compared to fluoroquinolones in areas with high fluoroquinolone resistance, particularly for Campylobacter infections 1, 3, 5
  • Clinical cure rates at 72 hours were highest (96%) with single-dose azithromycin compared to levofloxacin (71%) in Thailand 5
  • Azithromycin is effective against multiple pathogens including Campylobacter, Shigella, enteroinvasive E. coli, and other invasive bacteria 1, 3
  • Single-dose azithromycin (1g) has shown the shortest median time to last unformed stool (35 hours) compared to other regimens 5

Regional Considerations

  • Fluoroquinolone resistance exceeds 85% for Campylobacter in Southeast Asia, making azithromycin clearly superior in this region 1, 5
  • Increasing fluoroquinolone resistance is being reported globally, not just in Southeast Asia 1, 3
  • Rifaximin should be avoided in regions where invasive pathogens are common, as it has documented treatment failures in up to 50% of such cases 3

Dosing Recommendations

  • Azithromycin: Single 1-gram dose or 500 mg daily for 3 days 1, 3, 5
  • Fluoroquinolones (e.g., ciprofloxacin): 500 mg twice daily for 1-3 days 6
  • Rifaximin: 200 mg three times daily for 3 days 2
  • Single-dose regimens are preferred when possible for better compliance 1, 4

Important Caveats

  • Antibiotic treatment should be reserved for moderate to severe cases to minimize antimicrobial resistance 1
  • There is an increasing association between travel, traveler's diarrhea, and antibiotic use with the acquisition of multidrug-resistant bacteria 1
  • Microbiological testing is recommended for severe or persistent symptoms or treatment failures 1
  • Persistent diarrhea (>14 days) may require further evaluation for specific pathogens 1
  • Post-dose nausea may occur with high-dose azithromycin (14% vs <6% with other regimens) but is generally mild and self-limited 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Travelers' diarrhea: antimicrobial therapy and chemoprevention.

Nature clinical practice. Gastroenterology & hepatology, 2005

Guideline

IV Azithromycin for Bacterial Gastroenteritis Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Research

Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007

Research

Prevention and treatment of traveler's diarrhea.

American family physician, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.